Revenues from Contracts and Significant Customers (Tables)
|12 Months Ended|
Dec. 31, 2018
|Disaggregation of Revenue||
The Company has four marketed products, Targadox®, Exelderm®, Luxamend® and Ceracade®. Substantially all of the Company’s product revenues are recorded in the U.S. Substantially all of the Company’s collaboration revenues are from its collaboration with TGTX. Revenues by product and collaborator are summarized as follows($
Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef